BSECompany Update16 Sept 2026 · 16 Sept 2026, 04:12 pm
Intimation about Schedule of Analyst / Institutional Investor Meeting on September 23 - 25, 2026
Neuland Laboratories Ltd · 524558
✦ AI Summary
Neuland Laboratories Ltd has announced its participation in a group analyst/institutional investor meeting from September 23-25, 2026, in Singapore.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
9dcf77fd-1a38-4a7a-a189-549201210711.pdf
View document text
September 16, 2026
BSE Limited The National Stock Exchange of India Ltd
Phiroze Jeejeebhoy Towers, 25th Floor, Exchange Plaza,
Dalal Street, Mumbai – 400 001 Bandra Kurla Complex
Bandra (E), Mumbai – 400 001
Scrip Code: 524558 Scrip Code: NEULANDLAB; Series: EQ
Dear Sir/Madam,
Sub: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst /
Institutional Investor Meetings
This is to inform you that the Company’s management will be participating in the following group
analyst/ investor meeting(s):
Date Name of the Analyst / Location Nature of the
Institutional Investor / Event meeting
September 23 - 25, Goldman Sachs Global Singapore Group meet /
2026 Healthcare CDMO Day One-on-One meet
Please note that the schedule & participant list of the aforesaid meeting(s) is subject to change
due to any exigencies on the part of Participants / Company.
This is for your information and records.
Thanking you
Yours Sincerely,
For Neuland Laboratories Limited
Sarada Bhamidipati
Company Secretary